BioCentury
ARTICLE | Company News

Cancer Research UK, University of Copenhagen, ADC Therapeutics deal

May 2, 2016 7:00 AM UTC

Cancer Research’s Cancer Research Technology subsidiary and the university granted ADC a license to antibodies against an undisclosed cancer-specific cell surface protein. ADC will use the antibodies ...